Fulcrum Asset Management’s Boston Scientific BSX Stock Holding History

Fulcrum Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.08M	Buy	47,763 +4,912	+11%	+$267K	0.21%	125
2026 Q1	$2.7M	Buy	42,851 +4,292	+11%	+$343K	0.41%	66
2025 Q4	$3.7M	Sell	38,559 -1,142	-3%	-$112K	1.03%	24
2025 Q3	$3.88M	Sell	39,701 -1,103	-3%	-$114K	1.07%	24
2025 Q2	$4.38M	Buy	+40,804	New	+$4.13M	1.25%	17
2022 Q1	–	Hold	0	–	–	–	182
2021 Q4	–	Hold	0	–	–	–	111
2021 Q3	–	Hold	0	–	–	–	112
2021 Q2	–	Hold	0	–	–	–	110
2021 Q1	–	Hold	0	–	–	–	103

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fulcrum Asset Management's BSX Position: Q2 2026 in Review

Fulcrum Asset Management increased its Boston Scientific (BSX) stake by 11% in Q2 2026, buying an estimated $267K and bringing the position to 47,763 shares worth $2.08M. The position accounts for 0.21% of the portfolio, ranked #125.

Fulcrum Asset Management first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.38M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Fulcrum Asset Management held 47,763 shares of Boston Scientific worth $2.08M as of Q2 2026.
Fulcrum Asset Management bought 4,912 Boston Scientific shares in Q2 2026, an estimated $267K.
Boston Scientific made up 0.21% of Fulcrum Asset Management's portfolio in Q2 2026, its #125 holding.
Fulcrum Asset Management first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
Fulcrum Asset Management's Boston Scientific position peaked at $4.38M in Q2 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Fulcrum Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.